SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2761Arena (ARNA) which had bounced on hopes that the FDA's requirements for apprtuck31/28/2011
2760Pluristem (PSTI) off 25% today on an offering. I know nada about the company. tuck-1/27/2011
2759Just make sure you are not using a three sided coin. :) Replying to others....kenhott-1/25/2011
2758I did have some dry powder, but I wasn't willing to risk much - 1k shares ontom pope-1/25/2011
2757Thanks Ken. I could be wrong here but this looks to me like a case of heads I wifred hayes-1/25/2011
2756Thx for your note, fred. I know many are interested in MNTA. I would suggest tkenhott-1/25/2011
2755mnta down 16 percent on another teva release saying they are close to approval. fred hayes-1/25/2011
2754Acorda (ACOR) now off 17% after receiving a negative opinion from CHMP. Cheers,tuck-1/21/2011
2753bad day to have slept in. :-(scaram(o)uche-1/21/2011
2752VVUS -16% on news Message 27109564tnsaf-1/21/2011
2751But not by the SEC, so all's still all right with the world.tom pope-1/20/2011
2750MNKD - CNBC suggested that this information leaked early as huge blocks of the sSteve Lokness-1/20/2011
2749mnkd -44% AH MannKind Shares Down As FDA Rejects Afrezza Diabetic TherapyIan@SI-1/19/2011
2748ISPH down 52% after announcing that the last trial of denufosol for CF didn'Jibacoa-1/3/2011
2747ALIM/PSDV off sharply in AH trading on FDA rejection of Iluvien: siliconinvestoDewDiligence_on_SI-12/23/2010
2746CYTK: This might be a buying op. There are some unkowns to me, having not listetuck-12/13/2010
2745CYTK down 20+ (on the ALS news?)mopgcw-12/13/2010
2744Aastrom (ASTM) off 23% on a financing. Cheers, Tucktuck-12/10/2010
2743Investors reached such a conclusion with respect to SemBioSys, a defunct CanadiaDewDiligence_on_SI-11/18/2010
2742Tuck, For a small poorly funded Canadian Company to get the resources needed toIan@SI-11/18/2010
2741Well, the trial was mostly to inform the upcoming ASSURE-1 trial, yes? I think tuck-11/18/2010
2740Resverlogix down 40% after presenting clinical data at AHA that was inferiour byIan@SI-11/17/2010
2739Deerfield has a fist-full of hgsi puts.keokalani'nui-11/16/2010
2738HGSI -15% at day's low, closed -10% after FDA Staff's comments on Benlystnsaf-11/12/2010
2737BIOD, probably ~50% on FDA CRL: siliconinvestor.comDewDiligence_on_SI-11/1/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News